Stanley C. Erck

Insider Reports History

Entity
Individual
Location
20 Firstfield Road, #250, Gaithersburg, MD
Signature
/s/ Brian Leaf, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stanley C. Erck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MAXCYTE, INC. Director Common Stock 269K $1M $3.72 Nov 1, 2024 Direct
NOVAVAX INC President and CEO, Director Common Stock 36.5K $155K $4.26 Dec 14, 2022 Direct
NOVAVAX INC President and CEO, Director Restricted Stock Units 6.97K $39.6K $5.69 Dec 14, 2022 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 40.7K Jun 11, 2024 Direct
MAXCYTE, INC. Director Employee Stock Option (right to buy) 0 Nov 1, 2024 Direct

Insider Reports Filed by Stanley C. Erck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MXCT MAXCYTE, INC. Nov 1, 2024 3 -$175K 4 Nov 5, 2024 Director
MXCT MAXCYTE, INC. Oct 1, 2024 6 -$177K 4 Oct 2, 2024 Director
MXCT MAXCYTE, INC. Sep 3, 2024 6 -$190K 4 Sep 5, 2024 Director
MXCT MAXCYTE, INC. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
MXCT MAXCYTE, INC. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
NVAX NOVAVAX INC Dec 14, 2022 3 -$40K 4 Dec 16, 2022 President and CEO, Director
NVAX NOVAVAX INC Sep 26, 2022 3 -$41.1K 4 Sep 28, 2022 President and CEO, Director
MXCT MAXCYTE, INC. Jun 29, 2022 1 $0 4 Jul 8, 2022 Director
NVAX NOVAVAX INC Mar 10, 2022 2 $0 4 Mar 14, 2022 President and CEO, Director
NVAX NOVAVAX INC Dec 14, 2021 3 -$567K 4 Dec 16, 2021 President and CEO, Director
NVAX NOVAVAX INC Oct 4, 2021 14 -$6.37M 4 Oct 5, 2021 President and CEO, Director
NVAX NOVAVAX INC Oct 1, 2021 27 -$7.25M 4 Oct 5, 2021 President and CEO, Director
NVAX NOVAVAX INC Sep 26, 2021 3 -$785K 4 Sep 28, 2021 President and CEO, Director
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
NVAX NOVAVAX INC Jul 1, 2021 30 -$15.1M 4 Jul 6, 2021 President and CEO, Director